Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
In Pharma Media, Intent Is Becoming The Thing You Actually Buy
Kamya Elawadhi is Co-Founder and President at Doceree. For most of the history of pharma marketing, the unit of value has been reach. Brands have paid to be seen by as many of the right physicians as possible, and success has been measured in…
Guardian Pharma (GRDN) Q3 2026 Earnings Call Transcript
Vice President, Investor Relations - Ashley Stockton President and Chief Executive Officer - Fred Burke Chief Operating Officer - David Morris Chief Financial Officer - Will Mudd Residents Served -- 218,000, representing 7% growth compared to the…
Mayne Pharma sells Adelaide plant to focus on US
Mayne Pharma has agreed to sell its Adelaide manufacturing plant as part of a $55 million deal to offload its international segment to Genesis Capital following pressure from shareholders to break up the company after a $672 million takeover bid…
ARS Pharma (SPRY) Q3 2026 Earnings Call Transcript
President and Chief Executive Officer - Donn Casale Chief Commercial Officer - Meg Smith Chief Financial Officer - Kathleen Scott IR Representative - Monique Allaire Total Revenue -- $37.7 million, increasing from $32.5 million in the third quarter…
Eton Pharma (ETON) Q3 2026 Earnings Call Transcript
Chief Business Officer - David Krempa Chief Executive Officer - Sean Brynjelsen Chief Commercial Officer - Ipek Trinkaus Chief Financial Officer - Judith Matthews Net Revenue -- $57.9 million, representing 158% year-over-year growth driven by the…
Ginkgo reaffirms 2026 cash burn guidance of $125M-$150M while outlining first pharma autonomous lab sale to Novo Nordisk (NYSE:DNA)
Earnings Call Insights: Ginkgo Bioworks (DNA) Q3 2026 “Over the last few years, we've been going through a transformation with this focus on autonomous labs, and that was really our goal in 2026. I would say I think that succeeded very…
Nuvectis Pharma (NASDAQ:NVCT) Shares Up 12.5% - Still a Buy?
Nuvectis Pharma, Inc. (NASDAQ:NVCT - Get Free Report)'s stock price rose 12.5% during mid-day trading on Friday. The company traded as high as $19.89 and last traded at $19.9810. Approximately 48,170 shares changed hands during mid-day trading, a…
Iovance Q3 Earnings: Why I'm Reiterating My Buy Call Despite Market Reaction (NASDAQ:IOVA)
Iovance Biotherapeutics, Inc., delivered strong Q3 results, with revenues up ~80% YoY and gross margin rising to 60%. IOVA reaffirmed 2026 guidance of $410–$420M revenue, and maintains a robust cash position ($376M) expected to last into…
How to predict the behavior of molecules from scant data
Discovering new molecules for specific uses is a major driver of progress in a wide variety of industries, whether it's pharmaceutical companies looking for new drugs, or electronics or energy companies seeking new materials with particular…
Novo Nordisk Owns The Oral Weight Loss Market At 7.8x Operating Income (NYSE:NVO)
Novo Nordisk A/S is upgraded to Strong Buy, driven by robust Q3 results and accelerating Wegovy pill adoption. Novo Nordisk trades at just 7.8x trailing operating income, well below pharma peers, supporting a value-driven investment thesis.
Intellia: Quiet Q3 Earnings As All Eyes Turn To March 2027 Approval Decision
Intellia Therapeutics approaches a pivotal FDA decision in March 2027 for lonvo-z, potentially the first in vivo CRISPR therapy for hereditary angioedema. Lonvo-z's Phase 3 data showed ~87% attack reduction and a clean safety profile, positioning…
Novartis reports cases of tumours in children following treatment with Zolgensma
The treatment, hailed as a medical breakthrough in 2019, is now coming under scrutiny due to potential safety risks. Novartis said in a press release that nine reports of tumours in children treated with Zolgensma have been received since the…
ARS Pharmaceuticals, Inc. (SPRY) Q3 2026 Earnings Call Transcript
ARS Pharmaceuticals, Inc. (SPRY) Q3 2026 Earnings Call November 5, 2026 4:30 PM EST Donn Casale - CEO, President & Director Kathleen Scott - Chief Financial Officer Monique Allaire - Thrust Strategic Communications Joshua Schimmer - Cantor…
Doximity outlines FY 2027 revenue of $678M-$683M as AI search reaches 8-figure bookings (NYSE:DOCS)
Earnings Call Insights: Doximity (DOCS) Q2 fiscal 2027 'Revenue was $175 million in Q2, up 4% year-over-year' (Co-Founder, CEO & Chairperson Jeffrey Tangney) and 'our Q2 adjusted EBITDA margin was 51% or $89 million' (CEO Tangney), alongside 'over…
Doximity (DOCS) Q2 2027 Earnings Call Transcript
Investor Relations - Perry Scott Gold Cofounder and Chief Executive Officer - Jeffrey A. Tangney Chief Financial Officer - Matthew Sonefeldt Revenue -- $174.5 million, representing 4% year-over-year growth and exceeding the high end of quarterly…
Receive a Daily briefing on Pharma Industry News
Get Started